IBM Enriches Health Data Mine With Truven
This article was originally published in Clinica
IBM says its Watson Health division will boast “the largest and most diverse” repositories of health-related data, after sealing a $2.6bn deal to acquire Truven Health Analytics. The deal, IBM’s fourth healthcare data-related acquisition in less than 12 months, will bring more than 8,500 new clients, including US federal and state government agencies, employers, health plans, hospitals, clinicians and life sciences companies, to Watson Health’s portfolio.
You may also be interested in...
Investment firm Francisco Partners will acquire IBM’s Watson Health’s data and analytics assets – including Micromedex, MarketScan, and Clinical Development – for an undisclosed price.
IBM is getting more heavily invested in the medical device industry, announcing two major partnerships this week with diagnostic-maker Illumina and US FDA. The move is part of a larger industry trend of tech firms becoming more active in the medtech sector, and AdvaMed is adjusting to the new context.
Siemens Healthineers will be offering population health management solutions for the first time, as it teams up with IBM Watson Health. Verily and 3M are also joining the PHM partnering wave.